Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
You do not get 1.4 to 1.6 percentage point reductions from a baseline of 7.7% out of a molecule that is meaningfully impairing glucose handling
17, 2024, has been updated to reflect new information
TRIUMPH-4 confirmed: Retatrutide 28.7% weight loss in Phase 3 (December 2025) final data, not preliminary TRIUMPH-1 confirmed (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients without diabetes pivotal trial met all primary endpoints TRANSCEND-T2D-1 confirmed (June 2026): -2.0% HbA1c and 16.8% weight loss in type 2 diabetes patients a separate diabetes-specific Phase 3 program Filing timeline updated: Eli Lilly will submit a Biologics License Application (BLA) not an NDA, since retatrutide is a biologic expected Q1 2027 (shifted from the previously estimated Q4 2026) Availability updated: Retatrutide remains investigational
If youre like me and want to use B12 supplements to prevent deficiency but arent in a position where injections are necessary, you can use an oral supplement to great effect
The GLOW Peptide protocol is typically administered through subcutaneous injections
The combination of cinnamon's insulin sensitivity effects and GLP-1 medications can potentially cause blood sugar to drop too low
